384 related articles for article (PubMed ID: 26526158)
1. Apolipoprotein E4 reduces evoked hippocampal acetylcholine release in adult mice.
Dolejší E; Liraz O; Rudajev V; Zimčík P; Doležal V; Michaelson DM
J Neurochem; 2016 Feb; 136(3):503-9. PubMed ID: 26526158
[TBL] [Abstract][Full Text] [Related]
2. Reversal of ApoE4-Driven Brain Pathology by Vascular Endothelial Growth Factor Treatment.
Salomon-Zimri S; Glat MJ; Barhum Y; Luz I; Boehm-Cagan A; Liraz O; Ben-Zur T; Offen D; Michaelson DM
J Alzheimers Dis; 2016 Jun; 53(4):1443-58. PubMed ID: 27372644
[TBL] [Abstract][Full Text] [Related]
3. Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid beta peptides but not on plaque formation.
Buttini M; Yu GQ; Shockley K; Huang Y; Jones B; Masliah E; Mallory M; Yeo T; Longo FM; Mucke L
J Neurosci; 2002 Dec; 22(24):10539-48. PubMed ID: 12486146
[TBL] [Abstract][Full Text] [Related]
4. The isoform-specific pathological effects of apoE4 in vivo are prevented by a fish oil (DHA) diet and are modified by cholesterol.
Kariv-Inbal Z; Yacobson S; Berkecz R; Peter M; Janaky T; Lütjohann D; Broersen LM; Hartmann T; Michaelson DM
J Alzheimers Dis; 2012; 28(3):667-83. PubMed ID: 22057027
[TBL] [Abstract][Full Text] [Related]
5. Altered acetylcholine release in the hippocampus of dystrophin-deficient mice.
Parames SF; Coletta-Yudice ED; Nogueira FM; Nering de Sousa MB; Hayashi MA; Lima-Landman MT; Lapa AJ; Souccar C
Neuroscience; 2014 Jun; 269():173-83. PubMed ID: 24704431
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E4 causes early olfactory network abnormalities and short-term olfactory memory impairments.
Peng KY; Mathews PM; Levy E; Wilson DA
Neuroscience; 2017 Feb; 343():364-371. PubMed ID: 28003161
[TBL] [Abstract][Full Text] [Related]
7. Learning, memory and the expression of cholinergic components in mice are modulated by the pesticide chlorpyrifos depending upon age at exposure and apolipoprotein E (APOE) genotype.
Basaure P; Guardia-Escote L; Cabré M; Peris-Sampedro F; Sánchez-Santed F; Domingo JL; Colomina MT
Arch Toxicol; 2019 Mar; 93(3):693-707. PubMed ID: 30656380
[TBL] [Abstract][Full Text] [Related]
8. Extra-Hippocampal Learning Deficits in Young Apolipoprotein E4 Mice and Their Synaptic Underpinning.
Har-Paz I; Roisman N; Michaelson DM; Moran A
J Alzheimers Dis; 2019; 72(1):71-82. PubMed ID: 31561365
[TBL] [Abstract][Full Text] [Related]
9. Central and Peripheral Mechanisms in ApoE4-Driven Diabetic Pathology.
Koren-Iton A; Salomon-Zimri S; Smolar A; Shavit-Stein E; Dori A; Chapman J; Michaelson DM
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32075060
[TBL] [Abstract][Full Text] [Related]
10. ApoE4 induces Aβ42, tau, and neuronal pathology in the hippocampus of young targeted replacement apoE4 mice.
Liraz O; Boehm-Cagan A; Michaelson DM
Mol Neurodegener; 2013 May; 8():16. PubMed ID: 23684315
[TBL] [Abstract][Full Text] [Related]
11. The effects of apolipoproteins E3 and E4 on the transforming growth factor-β system in targeted replacement mice.
Haas A; Liraz O; Michaelson DM
Neurodegener Dis; 2012; 10(1-4):41-5. PubMed ID: 22301441
[TBL] [Abstract][Full Text] [Related]
12. Hippocampus-related cognitive impairments in young apoE4 targeted replacement mice.
Salomon-Zimri S; Boehm-Cagan A; Liraz O; Michaelson DM
Neurodegener Dis; 2014; 13(2-3):86-92. PubMed ID: 24080852
[TBL] [Abstract][Full Text] [Related]
13. ApoE4 induces synaptic and ERG impairments in the retina of young targeted replacement apoE4 mice.
Antes R; Ezra-Elia R; Weinberger D; Solomon A; Ofri R; Michaelson DM
PLoS One; 2013; 8(5):e64949. PubMed ID: 23741431
[TBL] [Abstract][Full Text] [Related]
14. Observation of the density and size of cells in hippocampus and vascular lesion in thalamus of GFAP-apoE transgenic mice.
Tang KF; Cai L; Zhou JN
Neurosci Bull; 2009 Aug; 25(4):167-78. PubMed ID: 19633698
[TBL] [Abstract][Full Text] [Related]
15. Impaired hippocampal acetylcholine release parallels spatial memory deficits in Tg2576 mice subjected to basal forebrain cholinergic degeneration.
Laursen B; Mørk A; Plath N; Kristiansen U; Bastlund JF
Brain Res; 2014 Jan; 1543():253-62. PubMed ID: 24231553
[TBL] [Abstract][Full Text] [Related]
16. VEGF Mediates ApoE4-Induced Neovascularization and Synaptic Pathology in the Choroid and Retina.
Antes R; Salomon-Zimri S; Beck SC; Garcia Garrido M; Livnat T; Maharshak I; Kadar T; Seeliger M; Weinberger D; Michaelson DM
Curr Alzheimer Res; 2015; 12(4):323-34. PubMed ID: 25817253
[TBL] [Abstract][Full Text] [Related]
17. Human apolipoprotein E4 modulates the expression of Pin1, Sirtuin 1, and Presenilin 1 in brain regions of targeted replacement apoE mice.
Lattanzio F; Carboni L; Carretta D; Rimondini R; Candeletti S; Romualdi P
Neuroscience; 2014 Jan; 256():360-9. PubMed ID: 24161275
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E4 decreases whereas apolipoprotein E3 increases the level of secreted amyloid precursor protein after closed head injury.
Ezra Y; Oron L; Moskovich L; Roses AD; Beni SM; Shohami E; Michaelson DM
Neuroscience; 2003; 121(2):315-25. PubMed ID: 14521991
[TBL] [Abstract][Full Text] [Related]
19. Activation of the amyloid cascade in apolipoprotein E4 transgenic mice induces lysosomal activation and neurodegeneration resulting in marked cognitive deficits.
Belinson H; Lev D; Masliah E; Michaelson DM
J Neurosci; 2008 Apr; 28(18):4690-701. PubMed ID: 18448646
[TBL] [Abstract][Full Text] [Related]
20. Postnatal chlorpyrifos exposure and apolipoprotein E (APOE) genotype differentially affect cholinergic expression and developmental parameters in transgenic mice.
Basaure P; Guardia-Escote L; Cabré M; Peris-Sampedro F; Sánchez-Santed F; Domingo JL; Colomina MT
Food Chem Toxicol; 2018 Aug; 118():42-52. PubMed ID: 29729306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
